Category Archives: MS Treatment

The Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say it's shameful that Bill S-204 was squelched in committee. "This bill is dead, the Conservatives killed it," said Sen. Jim Munson. "Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law." The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. "They don't want to hear from MS patients, to have them as witnesses before the committee," said Sen. Jane Cordy, sponsor of the bill. "This is shameful." The Conservative senators argued this is a matter for science and medicine, not Parliament. "Since Day 1, the Conservatives have played politics with MS patients," Cordy said. The government has promised clinical trials of the therapy and a national register of patients, although neither the trials nor the registry have started. The bill … Continue reading →

OTTAWA The Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say its shameful that Bill S-204 was squelched in committee. This bill is dead, the Conservatives killed it, said Sen. Jim Munson. Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law. The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. They dont want to hear from MS patients, to have them as witnesses before the committee, said Sen. Jane Cordy, sponsor of the bill. This is shameful. The Conservative senators argued this is a matter for science and medicine, not Parliament. Since Day 1, the Conservative have played politics with MS patients, Cordy said. The Conservative senators on that committee threw the science away and have used politics, politics, politics. Cordy says as many as 75,000 Canadians suffer from … Continue reading →

OTTAWAThe Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say its shameful that Bill S-204 was squelched in committee. This bill is dead, the Conservatives killed it, said Senator Jim Munson. Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law. The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. They dont want to hear from MS patients, to have them as witnesses before the committee, said Senator Jane Cordy, sponsor of the bill. This is shameful. The Conservative senators argued this is a matter for science and medicine, not Parliament. Since Day 1, the Conservative have played politics with MS patients, Cordy said. The Conservative senators on that committee threw the science away and have used politics, politics, politics. Cordy says as many as 75,000 Canadians suffer from MS. … Continue reading →

Advances in MS Treatment with Dr. Avasarala From:saintfranciscapeViews:4 0ratingsTime:01:03More inEducation Read more from the original source: Advances in MS Treatment with Dr. Avasarala - Video … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company, (EURONEXT: SAN and NYSE: SNY) announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). The TGA approval will enable health professionals to prescribe AUBAGIO 14 mg in Australia, which is now the second country to gain marketing authorization for the treatment, following FDA approval in September. We are very pleased with the TGA approval of AUBAGIO that makes available a new option for healthcare professionals, and people living with MS in Australia who may benefit from this once-daily, oral treatment, said Bill Sibold, Head of Multiple Sclerosis, Genzyme. The availability of AUBAGIO in the U.S. and subsequent registration in Australia not only demonstrates our continued progress, it also reflects our commitment to deliver differentiated treatments and provide access for patients globally. The TGAs approval of AUBAGIO was based on safety and efficacy data from the TEMSO (TEriflunomide Multiple Sclerosis Oral) trial. The ongoing AUBAGIO clinical development program, involving more than 5,000 patients in 36 countries including Australia, is amongst the largest of any MS therapy. Some patients in extension trials have … Continue reading →

By Lucy Elkins PUBLISHED: 18:37 EST, 19 November 2012 | UPDATED: 11:59 EST, 20 November 2012 'I am a coper. I take each day as it comes,' said Janis Winehouse Janis Winehouse has had to face more than her fair share of tragedy. She watched as her singer daughter Amys rise to global superstardom was marred by drink and drug addiction, ending with her death in July last year at the age of 27. Last year took its toll physically and mentally, she says quietly. Yet Janis has her own battles to fight. For more than 30 years she has had multiple sclerosis (MS), and as her daughters life was spiralling out of control, Janiss health was taking a turn for the worse. Today, her right leg is so stiff she can only limp a few hundred yards at a time. Her memory is affected and she has also suffered with an overly sensitive bladder an embarrassing and debilitating part of MS, which causes incontinence. Originally posted here: Amy Winehouse's mother: How Botox helped her cope with her MS … Continue reading →

By John von Radowitz Monday, November 19, 2012 Tiny synthetic particles could help scientists to develop vaccines against immune response diseases such as multiple sclerosis (MS), research has shown. The "nanoparticles" trick the immune system into calming down and behaving normally. In tests on mice, they halted a rodent version of relapsing-remitting MS, the most common form of the autoimmune disease. Scientists believe the technology could be applied to a range of immune system disorders, including type-1 diabetes, food allergies, and asthma. MS occurs when the immune system attacks myelin, the fatty insulation that surrounds nerve fibres. Breaks in the myelin coating prevent nerve messages being transmitted properly, leading to symptoms ranging from numbness and tingling to full-blown paralysis. Current treatments for MS rely on suppressing the immune system, which can make patients susceptible to infections and cancer. Instead, the nanoparticle vaccine re-sets the immune system to stop the "friendly fire" attacks. The nanoparticles, made from two biodegradable compounds that naturally occur in the body, are attached to myelin proteins. The rest is here: ‘Nanoparticles’ may help scientists develop MS jab … Continue reading →

Jack Osbourne was diagnosed with multiple sclerosis earlier this year after he lost 60 per cent of his vision in his right eye (Reuters) A scientific breakthrough has arrested the development of multiple sclerosis in mice and has implications for a new treatment for the degenerative disease. Researchers at Northwestern University in Illinois found a new nanoparticle that tricks and resets the immune systems of mice with MS. MS is a neurological disease that affects around 100,000 people in the UK. It is mostly diagnosed in people who are aged between 20 and 40. A substance called myelin protects nerve fibres in the central nervous system. When people have MS, their immune system, which would normally fight off infections, mistakes myelin for a foreign body and attacks it. These attacks damage the myelin and strips it of nerve fibres. Over time, this nerve damage causes the accumulation of disability. The new nanoparticle works by delivering an antigen that makes the immune system stop its attack on myelin and halt relapsing remitting MS in mice. Around 80 per cent of people with MS are diagnosed with the relapsing remitting form of the disease. People who suffer from relapsing remitting MS have … Continue reading →

By Maggie Fox, NBC News Researchers trying to find a way to treat multiple sclerosis think theyve come up with an approach that could not only help patients with MS, but those with a range of so-called autoimmune diseases, from type-1 diabetes to psoriasis, and perhaps even food allergies. So far its only worked in mice, but it has worked especially well. And while mice are different from humans in many ways, their immune systems are quite similar. If this works, it is going to be absolutely fantastic, said Bill Heetderks, who directs outside research at the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health, which helped pay for the research. Even if it doesnt work, its going to be another step down the road. In autoimmune disease, the bodys immune cells mistakenly attack and destroy healthy tissue. In MS, its the fatty protective sheath around the nerves; in type-1 or juvenile diabetes its cells in the pancreas that make insulin; in rheumatoid arthritis its tissue in the joint. Currently, the main treatment is to suppress the immune system, an approach that can leave patients vulnerable to infections and cancer. The new treatment re-educates … Continue reading →

Scientists have developed a way of modifying a microscopic particle which could offer a new approach to tackling major diseases such as multiple sclerosis, Type 1 diabetes, asthma and food allergies. Instead of taking a drug that suppresses the entire immune system, making sufferers more susceptible to infections and cancer, patients may in future be given a nanoparticle treatment which can selectively inhibit the part of the immune system responsible for their disease. When primed, the nanoparticle can trick the immune system into halting its attack on the body which is a characteristic of these diseases. Researchers from Northwestern University in the US, funded by the National Institutes for Health, used the technique to block the progression of multiple sclerosis in mice. In MS, the immune system attacks the protective myelin sheath that surrounds the nerve fibres in the brain and spinal cord, causing symptoms ranging from numbness to paralysis. They injected nanoparticles attached to myelin antigens - proteins to stop the immune system from recognising the myelin sheath as an alien invader - which reset the immune system to normal and halted the attack. Stephen Miller , a professor of microbiology and one of the authors of the study, … Continue reading →